Summary

The Global Life Science Instrumentation Market is valued at approximately USD 62.24 billion in 2024 and is expected to expand at a CAGR of over 4.70% during the forecast period 2025–2035. Life science instrumentation, an indispensable pillar of biomedical research and clinical diagnostics, plays a vital role in transforming raw scientific inquiry into actionable medical knowledge. These sophisticated tools—which include technologies such as spectroscopy and chromatography—form the backbone of laboratory operations across pharmaceutical, clinical, and academic research facilities. Amid the rapid escalation of global health challenges and the unrelenting demand for innovation in drug development and disease detection, life science instrumentation continues to witness remarkable growth. The widespread integration of these technologies into precision medicine, genomics, proteomics, and biotechnology research further bolsters their adoption worldwide.
One of the key driving forces accelerating market expansion is the surge in research and development (R&D) activities across the pharmaceutical and biotechnology sectors. Growing investments in new drug discovery, personalized therapies, and molecular diagnostics are pushing demand for high-performance analytical tools. Technologies such as chromatography and spectroscopy have become indispensable for identifying compounds, detecting impurities, and analyzing complex biological samples. For example, the increased reliance on mass spectrometry for biomarker discovery or HPLC for purity profiling is reshaping the competitive landscape. Moreover, the emergence of high-throughput platforms and automation has drastically improved laboratory workflow efficiency, making these instruments more appealing to end-users ranging from hospitals to biopharmaceutical companies. While the market flourishes with opportunity, it is also tethered to challenges such as the high capital cost of instrumentation, the complexity of integration, and stringent regulatory frameworks, especially in clinical diagnostic environments.
From a geographical standpoint, North America leads the charge in the life science instrumentation market, underpinned by its robust infrastructure for biomedical research, substantial government funding, and the presence of leading instrument manufacturers. The United States, in particular, boasts an expansive ecosystem of life science research and diagnostics labs, facilitating widespread uptake of advanced technologies. Europe follows closely, driven by initiatives such as Horizon Europe, which supports scientific innovation across the region. Meanwhile, the Asia Pacific region is anticipated to experience the fastest growth over the forecast period. Rapid industrialization, increasing healthcare expenditure, and a rising number of clinical trials in countries such as China, India, and South Korea are driving investments in modern research infrastructure. Additionally, collaborations between academic institutions and industry players are fueling the integration of cutting-edge analytical technologies across the region’s scientific landscape.
Major market player included in this report are:
• Thermo Fisher Scientific Inc.
• Agilent Technologies Inc.
• Danaher Corporation
• PerkinElmer Inc.
• Shimadzu Corporation
• Waters Corporation
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• GE Healthcare
• Hitachi High-Tech Corporation
• F. Hoffmann-La Roche Ltd
• Illumina Inc.
• Merck KGaA
• Horiba Ltd.
• Sartorius AG
Global Life Science Instrumentation Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period – 2025-2035
• Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope – Free report customization (equivalent up to 8 analysts’ working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:
By Technology:
• Spectroscopy
• Chromatography
By Application:
• Research Applications
• Clinical and Diagnostics Applications
By End-User:
• Hospitals and Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1. Global Life Science Instrumentation Market Report Scope & Methodology
1.1. Research Objective
1.2. Research Methodology
 1.2.1. Forecast Model
 1.2.2. Desk Research
 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
 1.4.1. Market Definition
 1.4.2. Market Segmentation
1.5. Research Assumption
 1.5.1. Inclusion & Exclusion
 1.5.2. Limitations
 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary
2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings

Chapter 3. Global Life Science Instrumentation Market Forces Analysis
3.1. Market Forces Shaping The Global Life Science Instrumentation Market (2024-2035)
3.2. Drivers
 3.2.1. Surge in R&D and Drug Discovery Activities
 3.2.2. Rise in Demand for Precision Medicine and Personalized Healthcare
3.3. Restraints
 3.3.1. High Cost of Advanced Analytical Instruments
 3.3.2. Need for Skilled Workforce and Specialized Expertise
3.4. Opportunities
 3.4.1. Emerging Biotech Hubs in Asia Pacific and Latin America
 3.4.2. Increasing Government and Private Funding in Life Sciences Research

Chapter 4. Global Life Science Instrumentation Industry Analysis
4.1. Porter’s 5 Forces Model
 4.1.1. Bargaining Power of Buyer
 4.1.2. Bargaining Power of Supplier
 4.1.3. Threat of New Entrants
 4.1.4. Threat of Substitutes
 4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Forecast Model (2024–2035)
4.3. PESTEL Analysis
 4.3.1. Political
 4.3.2. Economical
 4.3.3. Social
 4.3.4. Technological
 4.3.5. Environmental
 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024–2025)
4.7. Global Pricing Analysis and Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Life Science Instrumentation Market Size & Forecasts by Technology 2025–2035
5.1. Market Overview
5.2. Spectroscopy
 5.2.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
 5.2.2. Market Size Analysis, by Region, 2025–2035
5.3. Chromatography
 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
 5.3.2. Market Size Analysis, by Region, 2025–2035

Chapter 6. Global Life Science Instrumentation Market Size & Forecasts by Application 2025–2035
6.1. Market Overview
6.2. Research Applications
 6.2.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
 6.2.2. Market Size Analysis, by Region, 2025–2035
6.3. Clinical and Diagnostics Applications
 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
 6.3.2. Market Size Analysis, by Region, 2025–2035

Chapter 7. Global Life Science Instrumentation Market Size & Forecasts by End-User 2025–2035
7.1. Market Overview
7.2. Hospitals and Diagnostic Laboratories
 7.2.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
 7.2.2. Market Size Analysis, by Region, 2025–2035
7.3. Pharmaceutical and Biotechnology Companies
 7.3.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
 7.3.2. Market Size Analysis, by Region, 2025–2035

Chapter 8. Global Life Science Instrumentation Market Size & Forecasts by Region 2025–2035
8.1. Regional Market Snapshot
8.2. Top Leading & Emerging Countries
8.3. North America Life Science Instrumentation Market
 8.3.1. U.S.
  8.3.1.1. Technology Breakdown Size & Forecasts, 2025–2035
  8.3.1.2. Application Breakdown Size & Forecasts, 2025–2035
 8.3.2. Canada
  8.3.2.1. Technology Breakdown Size & Forecasts, 2025–2035
  8.3.2.2. Application Breakdown Size & Forecasts, 2025–2035
8.4. Europe Life Science Instrumentation Market
 8.4.1. UK
 8.4.2. Germany
 8.4.3. France
 8.4.4. Spain
 8.4.5. Italy
 8.4.6. Rest of Europe
8.5. Asia Pacific Life Science Instrumentation Market
 8.5.1. China
 8.5.2. India
 8.5.3. Japan
 8.5.4. Australia
 8.5.5. South Korea
 8.5.6. Rest of Asia Pacific
8.6. Latin America Life Science Instrumentation Market
 8.6.1. Brazil
 8.6.2. Mexico
8.7. Middle East & Africa Life Science Instrumentation Market
 8.7.1. UAE
 8.7.2. Saudi Arabia
 8.7.3. South Africa
 8.7.4. Rest of Middle East & Africa

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Thermo Fisher Scientific Inc.
 9.2.1. Company Overview
 9.2.2. Key Executives
 9.2.3. Company Snapshot
 9.2.4. Financial Performance (Subject to Data Availability)
 9.2.5. Product/Services Port
 9.2.6. Recent Development
 9.2.7. Market Strategies
 9.2.8. SWOT Analysis
9.3. Waters Corporation
9.4. Illumina Inc.
9.5. Bio-Rad Laboratories Inc.
9.6. Bruker Corporation
9.7. Agilent Technologies Inc.
9.8. Merck KGaA
9.9. Danaher Corporation
9.10. GE Healthcare
9.11. PerkinElmer Inc.
9.12. Shimadzu Corporation
9.13. F. Hoffmann-La Roche Ltd
9.14. Sartorius AG
9.15. Hitachi High-Tech Corporation
9.16. Horiba Ltd.